ETON Pharmaceuticals (NASDAQ: ETON) revenue
ETON Pharmaceuticals reported revenue of $80.0m for fiscal 2025, 104.9% more than in fiscal 2024 ($39.0m). Since fiscal 2019 its revenue has grown by 8,236.8%, an average growth of 109.0% a year.
ETON Pharmaceuticals has grown its revenue for 3 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record. The biggest drop was in fiscal 2020, −95.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $80.0m | +104.9% | −$0.8m | −1.1% |
| 2024 | $39.0m | +23.3% | −$2.6m | −6.7% |
| 2023 | $31.6m | +48.9% | −$1.2m | −3.8% |
| 2022 | $21.3m | −2.7% | −$8.3m | −38.9% |
| 2021 | $21.8m | +55,879.5% | −$1.5m | −6.8% |
| 2020 | $0.0m | −95.9% | −$27.1m | −69,515.4% |
| 2019 | $1.0m | — | −$18.6m | −1,939.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
ETON Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, ETON Pharmaceuticals ranks 302nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; ETON Pharmaceuticals, 104.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 300th | MeiraGTx | $81.4m | 144.6% |
| 301st | ADC Therapeutics | $81.4m | 14.9% |
| 302nd | ETON Pharmaceuticals | $80.0m | 104.9% |
| 303rd | Simulations Plus | $79.2m | 13.1% |
| 304th | Pro-DEX | $77.5m | 16.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of ETON Pharmaceuticals
- How much revenue did ETON Pharmaceuticals make in fiscal 2025?
- ETON Pharmaceuticals reported revenue of $80.0m for fiscal 2025, compared with $39.0m in fiscal 2024.
- How much has the revenue of ETON Pharmaceuticals grown?
- Between fiscal 2019 and fiscal 2025 it went from $1.0m to $80.0m: 8,236.8% more, an average growth of 109.0% a year.
- What was the best year for revenue at ETON Pharmaceuticals?
- Of its last 7 fiscal years, fiscal 2025, with $80.0m.
- Where does ETON Pharmaceuticals rank in its sector by revenue?
- It ranks 302nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for ETON Pharmaceuticals come from?
- From the annual report (Form 10-K) that ETON Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ETON Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on ETON Pharmaceuticals: the ETON Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.